Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 14507
Country/Region: Zambia
Year: 2015
Main Partner: FHI 360
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USDOD
Total Funding: $3,784,574 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $400,000
Care: TB/HIV (HVTB) $350,000
Care: Pediatric Care and Support (PDCS) $30,536
Laboratory Infrastructure (HLAB) $150,000
Strategic Information (HVSI) $250,000
Health Systems Strengthening (OHSS) $150,000
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Testing: HIV Testing and Counseling (HVCT) $400,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $200,000
Treatment: Adult Treatment (HTXS) $1,702,242
Treatment: Pediatric Treatment (PDTX) $151,796
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Age/sex: <1 Female 2016 110
CARE_CURR Age/sex: <1 Male 2016 18
CARE_CURR Age/sex: 1-4 Female 2016 215
CARE_CURR Age/sex: 1-4 Male 2016 310
CARE_CURR Age/sex: 10-14 Female 2016 740
CARE_CURR Age/sex: 10-14 Male 2016 714
CARE_CURR Age/sex: 15-19 Female 2016 1,790
CARE_CURR Age/sex: 15-19 Male 2016 1,502
CARE_CURR Age/sex: 20-24 Female 2016 2,985
CARE_CURR Age/sex: 20-24 Male 2016 2,758
CARE_CURR Age/sex: 25-49 Female 2016 2,060
CARE_CURR Age/sex: 25-49 Male 2016 3,500
CARE_CURR Age/sex: 5-9 Female 2016 740
CARE_CURR Age/sex: 5-9 Male 2016 528
CARE_CURR Age/sex: 50+ Female 2016 120
CARE_CURR Age/sex: 50+ Male 2016 110
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 18,200
CARE_CURR Sum of Age/Sex disaggregates 2016 18,200
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 3,938
PMTCT_ARV Maternal triple ARV prophylaxis (provided with the intention to stop at the end of the breastfeeding period) 2016 12
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 100
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 100
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 38
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 50
PMTCT_ARV Sum of New and Current disaggregates 2016 88
PMTCT_ARV Sum of Regimen Type disaggregates 2016 12
PMTCT_STAT By: Known positives at entry 2016 150
PMTCT_STAT By: Number of new positives identified 2016 100
PMTCT_STAT Number of new ANC and L&D clients 2016 2,309
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 2,309
PMTCT_STAT Sum of Positives Status disaggregates 2016 250
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 18,200
TX_CURR Age/Sex: <1 Female 2016 160
TX_CURR Age/Sex: <1 Male 2016 165
TX_CURR Age/Sex: 1-4 Female 2016 600
TX_CURR Age/Sex: 1-4 Male 2016 920
TX_CURR Age/Sex: 5-14 Female 2016 280
TX_CURR Age/Sex: 5-14 Male 2016 107
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 17,000
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 21,893
TX_CURR Sum of Age/Sex disaggregations 2016 17,000